Bafna Pharmaceuticals Limited — Others, 26-03-2025: Trading Window

BAFNA Pharmaceuticals has announced a board meeting on the closure of the trading window for designated persons and their immediate relatives, effective from April 1, 2025, until 48 hours after the declaration of the financial results for the quarter and financial year ending March 31, 2025. This action is in line with the company’s Code of Conduct for Prevention of Insider Trading.

Investors should be aware that this period of restricted trading may signal upcoming significant developments or performance disclosures, potentially highlighting volatility in stock performance around the results announcement. This could create both opportunities and risks for shareholders.